Assessment of Updated Evaluation Scores in Critically ILL COPD Patients Admitted to Assiut University Hospital
1 other identifier
observational
150
1 country
1
Brief Summary
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) represent a leading cause of morbidity and mortality.Patients admitted to hospital present higher mortality rates.The investigators lack the specific tools that allow us to easily classify and establish the individual prognosis for each patient during their hospitalization. Rational of the study:to identify the predictive factors for hospital mortality in critically ill patients admitted to hospital due to an episode of COPD exacerbation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 17, 2014
CompletedFirst Posted
Study publicly available on registry
October 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedApril 1, 2015
October 1, 2014
3 years
September 17, 2014
March 30, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Calculate the mortality of exacerbated patients based on APACHE II and SOFA score, respiratory rate upon admittance, age, pO2/ FiO2 in the first few hours of admittance.
Calculate mortality caused by AECOPD depend upon APACHE II and SOFA score
24 hours
Eligibility Criteria
We include for study all patients critically ill hospitalized for COPD exacerbation during the study period.
You may qualify if:
- We include for study all patients critically ill hospitalized for COPD exacerbation during the study period
You may not qualify if:
- Patients who refuse to be admitted to hospital after having been properly informed, and their families as well, of the possible risks that they are assuming.
- Specific diagnosis: pulmonary edema, rib fractures, aspiration, pleural effusion, etc. upon admission.
- Other associated respiratory pathology that determines treatment: pulmonary fibrosis, kyphoscoliosis, neuromuscular pathology, upper airway obstruction, extensive tuberculosis sequelae.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chest Department-faculty of medicine-Assuit university
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- chest department- faculity of medicine -Assiut university- Egypt
Study Record Dates
First Submitted
September 17, 2014
First Posted
October 8, 2014
Study Start
September 1, 2012
Primary Completion
September 1, 2015
Study Completion
December 1, 2015
Last Updated
April 1, 2015
Record last verified: 2014-10